ARTES Biotechnology https://validator.w3.org/feed/docs/rss2.html Cellumed and ARTES Sign Development and License Agreement ARTES Biotechnology ARTES Process Development VLP Vaccine Development Privacy Notice Partnership with Provenance aims in new designer collagen peptides Microbial Cell Line Development Enterokinase Monellin Downloads Technology Transfer Biosimilar Enzymes HBsAg adw2 Inorganic pyrophosphatase Endoglycosidase H Vaccines HPV33 L1 HPV18 L1 HPV16 L1 HPV11 L1 HPV6 L1 HPV31 L1 Human Serum Albumin T7 RNA Polymerase INTERFERON ALPHA 2B Bringing microbial CDMO services to BIO International 2025 in Boston Lab Reagents Facility Manufacturing INTERFERON ALPHA 2A Head of Molecular Biology at ARTES Brazzein Proteins for Diagnostics ARTES receives Renewal of French Research Tax Credit (CIR) Accreditation ARTES joins global combat against Corona ARTES part of “Worldwide, researchers work on coronavirus vaccine” ARTES and Burnet Institute publish data on new malaria vaccine candidates VLP purification patent granted in EU VLP Purification Patent granted in US Hansenula polymorpha METAVAX®-Platform Management Team ARTES backs “Initiative against Corona” Career News Contact Protected: Typo ARTES presenting at BIO-Europe Stockholm